Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  New England Journal of Medicine

• Publication date

  1993-03-04

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJM199303043280901PMID 8429851
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Six variants of HLA-1327 identified by isoelectric focusing

  2004cited by this paper
• Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies.

  1991cited by this paper
• Successful treatment of severe aplastic anemia by bone marrow transplantation from HLA nonidentical family members: preliminary results utilizing cyclophosphamide and 600 cGY fractionated total body irradiation.

  1991cited by this paper
• Future directions in selection of donors for bone marrow transplantation: role of oligonucleotide genotyping.

  1991cited by this paper
• Bone marrow transplantation from related donors other than HLA-identical siblings: effect of T cell depletion.

  1991cited by this paper
• Effects of treatment regimens on post marrow transplant relapse.

  1991cited by this paper
• Selection of unrelated donors for bone marrow transplantation is improved by HLA class II genotyping with oligonucleotide hybridization.

  1991cited by this paper
• PCR-fingerprinting for selection of HLA matched unrelated marrow donors. Collaborating Centres in the IMUST Study.

  1991cited by this paper
• Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: a randomized trial of two irradiation regimens.

  1991cited by this paper
• Bone marrow transplantation for chronic myeloid leukemia: the use of histocompatible unrelated volunteer donors.

  1990cited by this paper
• Bone marrow transplantation using unrelated donors for patients with advanced leukemia or bone marrow failure.

  1990cited by this paper
• Bone marrow transplantation for patients with myelodysplasia. Pretreatment variables and outcome.

  1990cited by this paper
• Bone marrow transplantation for myelodysplasia and secondary acute nonlymphoblastic leukemia.

  1990cited by this paper
• Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors.

  1990cited by this paper
• Unrelated donor marrow transplantation between 1977 and 1987 at four centers in the United Kingdom.

  1990cited by this paper
• Bone marrow transplants in chronic myelogenous leukemia: an overview of determinants of survival.

  1990cited by this paper
• Bone marrow transplantation for patients with myelodysplasia. Pretreatment variables and outcome.

  1990cited by this paper
• Epstein-Barr virus-associated B-cell lymphoproliferative disorders in immunodeficiency: meeting the challenge.

  1990cited by this paper
• Bone marrow transplantation for severe aplastic anemia in children.

  1990cited by this paper
• Therapy for chronic myelogenous leukemia with unrelated donor bone marrow transplantation: results in 102 cases.

  1990cited by this paper
• Bone marrow transplantation for children with myelodysplastic syndromes.

  1989cited by this paper
• Bone marrow transplantation for children with severe aplastic anemia: use of donors other than HLA-identical siblings.

  1989cited by this paper
• Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma.

  1989cited by this paper
• Timing of marrow transplantation in secondary leukemias and myelodysplastic syndromes.

  1989cited by this paper
• Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment results.

  1989cited by this paper
• Increasing utilization of bone marrow transplantation. II. Results of the 1985-1987 survey.

  1989cited by this paper
• HLA class II typing by restriction fragment length polymorphism (RFLP) in unrelated bone marrow transplant patients.

  1989cited by this paper
• Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia.

  1989cited by this paper
• PROBABILITY OF FINDING HLA‐MATCHED UNRELATED MARROW DONORS

  1988cited by this paper
• Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.

  1988cited by this paper
• Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.

  1988cited by this paper
• Partially matched bone marrow transplantation in patients with myelodysplastic syndromes.

  1988cited by this paper
• Allogeneic marrow grafting with partially mismatched, unrelated marrow donors.

  1988cited by this paper
• Bone marrow transplantation for severe aplastic anemia from donors other than HLA identical siblings: a report of the BMT Working Party.

  1988cited by this paper
• Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukemia.

  1987cited by this paper
• Graft rejection in recipients of T-cell-depleted HLA-nonidentical marrow transplants for leukemia. Identification of host-derived antidonor allocytotoxic T lymphocytes.

  1987cited by this paper
• Unrelated donor bone marrow transplantation therapy for chronic myelogenous leukemia.

  1987cited by this paper
• Bone marrow transplantation experience for children with aplastic anemia.

  1986cited by this paper
• Development and operation of a program to obtain volunteer bone marrow donors unrelated to the patient

  1986cited by this paper
• High-resolution analysis of the human HLA-DR polymorphism by hybridization with sequence-specific oligonucleotide probes.

  1986cited by this paper
• Transplantation of HLA-haploidentical T-cell-depleted marrow for leukemia: autologous marrow recovery with specific immune sensitization to donor antigens.

  1986cited by this paper
• Recruitment of unrelated persons as bone marrow donors. A preliminary experience

  1986cited by this paper
• Histocompatible unrelated volunteer donors compared with HLA nonidentical family donors in marrow transplantation for aplastic anemia and leukemia.

  1986cited by this paper
• An improved biochemical method for the analysis of HLA-class I antigens. Definition of new HLA-class I subtypes.

  1986cited by this paper
• Clinical trial depleting T lymphocytes from donor marrow for matched and mismatched allogeneic bone marrow transplants.

  1985cited by this paper
• Transplantation of HLA-haploidentical T-cell-depleted marrow for leukemia: addition of cytosine arabinoside to the pretransplant conditioning prevents rejection.

  1985cited by this paper
• Marrow transplantation from related donors other than HLA-identical siblings.

  1985cited by this paper
• Marrow transplantation for congenital disorders.

  1984cited by this paper
• Allogenic bone marrow transplantation: current status and future directions.

  1983cited by this paper
• BONE MARROW TRANSPLANTATION FOR SEVERE APLASTIC ANEMIA USING A PHENOTYPICALLY HLA‐IDENTICAL, SBCOMPATIBLE UNRELATED DONOR

  1983cited by this paper
• Analysis of human class I antigens by two-dimensional gel electrophoresis

  1983cited by this paper
• Karnofsky Memorial Lecture. Marrow transplantation for malignant diseases.

  1983cited by this paper
• Mismatched family donors for bone-marrow transplantation as treatment for acute leukaemia.

  1983cited by this paper
• Bone-marrow transplantation for severe aplastic anaemia using histocompatible unrelated volunteer donors.

  1982cited by this paper
• Bone marrow transplantation in acute leukemia.

  1982cited by this paper
• Bone marrow transplantation from unrelated volunteer donors: summary of a conference on scientific, ethical, legal, financial, and other practical issues

  1982cited by this paper
• Analysis of late infections after human bone marrow transplantation: role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host disease.

  1982cited by this paper
• Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation.

  1981cited by this paper
• Transplantation of marrow from an unrelated donor to a patient with acute leukemia.

  1980cited by this paper
• Reconstitution in severe combined immunodeficiency by transplantation of marrow from an unrelated donor.

  1977cited by this paper
• Treatment of severe combined immunodeficiency with bone-marrow from an unrelated, mixed-leucocyte-culture-non-reactive donor.

  1975cited by this paper
• Bone marrow transplantation for aplastic anaemia from a HL-A and MLC-identical unrelated donor

  1975cited by this paper
• Letter: X long-arm deletion with features of Turner's syndrome.

  1974cited by this paper
• CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S

  1974cited by this paper
• Marrow transplantation in aplastic anemia.

  1974cited by this paper
• Allogeneic bone marrow transplantation in a patient with aplastic anemia using a phenotypically HL-A-identifcal unrelated donor.

  1973cited by this paper
• Evaluation of survival data and two new rank order statistics arising in its consideration.

  1966cited by this paper

• Ex vivo mesenchymal progenitor cell-based cord blood cell expansion and exofucosylation to enhance transplant engraftment.

  2025cites this paper
• Outcomes with HLA-matched unrelated donor versus haploidentical hematopoietic cell transplantation

  2024cites this paper
• Incidence and risk factors for secondary graft failure in uniformly treated patients with severe aplastic anemia receiving fludarabine and cyclophosphamide for conditioning and matched sibling bone marrow graft as stem cell source.

  2023cites this paper
• Transgenic HA-1-Specific CD8+ T-Lymphocytes Selectively Target Leukemic Cells

  2023cites this paper
• T-cell depleted allogeneic hematopoietic stem cell transplant for the treatment of Fanconi anemia and MDS/AML

  2023influential citation
• Novel pre-clinical mouse models for chronic Graft-versus-Host Disease

  2023cites this paper
• Outcomes of two-step haploidentical allogeneic stem cell transplantation in elderly patients with hematologic malignancies

  2022cites this paper
• Outcomes with mismatched unrelated donor allogeneic hematopoietic stem cell transplantation in adults: A systematic review and meta-analysis

  2022influential citation
• Murine CAR19 Tregs suppress acute graft-versus-host disease and maintain graft-versus-tumor responses

  2022cites this paper
• Sequence Variations Within HLA-G and HLA-F Genomic Segments at the Human Leukocyte Antigen Telomeric End Associated With Acute Graft-Versus-Host Disease in Unrelated Bone Marrow Transplantation

  2022influential citation
• Comparable Outcomes of Matched Sibling Donor and Matched Unrelated Donor Stem Cell Transplantation in Children With Acute Leukemia in Argentina

  2021cites this paper
• Beyond steroids: A systematic review and proposed solutions to managing acute graft-versus-host disease in adolescents and young adults.

  2021cites this paper
• Switching from Intravenous to Oral Tacrolimus Reduces its Blood Concentration in Paediatric Cancer Patients

  2021cites this paper
• Predictors of a short hospitalization in bone marrow transplantation patients presenting to the emergency department.

  2021cites this paper
• Hematopoietic Stem Cell Transplantation, Where Have We Come and Where Do We Go.

  2020cites this paper
• Donor Heme Oxygenase-1 Promoter Gene Polymorphism Predicts Survival after Unrelated Bone Marrow Transplantation for High-Risk Patients

  2020cites this paper
• Cytoprotective effects of antioxidant supplementation on mesenchymal stem cell therapy

  2020cites this paper
• Clinical characteristics and outcomes of bone marrow transplantation patients presenting to the ED of a tertiary care center.

  2020cites this paper
• Graft Versus Host Disease: Management of Acute and Chronic Disease

  2020cites this paper
• Immunosuppressive Total Nodal Irradiation-Based Reconditioning Regimens After Graft Rejection or Graft Failure in Pediatric Patients Treated With Myeloablative Allogeneic Hematopoietic Cell Transplantation.

  2019cites this paper
• Principles of Hematopoietic Stem Cell Transplantation

  2019cites this paper
• Der Einfluss der Stammzellquelle auf das Therapieergebnis bei HLA-differenter allogener hämatopoetischer Stammzelltransplantation

  2019cites this paper
• Characterising the plasticity of cutaneous myeloid cells in graft-versus-host disease

  2019cites this paper
• Combined Approach to Treat Medication-Related Osteonecrosis of the Jaws.

  2018cites this paper
• Haploidentical Stem Cell Transplantation: A Gateway to Infrequent Availability of HLA-Matched Related Donors

  2018cites this paper
• The association of de novo anti-HLA-DPB1 donor-specific antibody formation and primary graft failure after allogeneic hematopoietic cell transplantation.

  2018cites this paper
• Genetically enhanced T lymphocytes and the intensive care unit

  2018cites this paper
• Cord Blood Transplantations

  2017cites this paper
• Complications and Results

  2017cites this paper
• Graft-Versus-Host Disease in Adolescents and Young Adults (15–24 Years Old) After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia in First Complete Remission

  2017cites this paper
• Hematopoietic Cell Transplants: Concepts, Controversies, and Future Directions

  2017cites this paper
• Randomized Control led Tria l o f Azac i t id ine in Pat ients With the Myelodysplas t ic Syndrome : A Study of the Cancer and Leukemia Group B

  2017cites this paper
• Limitations and Unique Complications of Umbilical Cord Blood Transplantation

  2017cites this paper
• Ex vivo T-cell depletion in allogeneic hematopoietic stem cell transplant: past, present and future

  2017cites this paper
• Correlation of rabbit antithymocyte globulin serum levels and clinical outcomes in children who received hematopoietic stem cell transplantation from an alternative donor

  2016cites this paper
• Gene Map of the HLA Region, Graves' Disease and Hashimoto Thyroiditis, and Hematopoietic Stem Cell Transplantation.

  2016cites this paper
• CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Factors Associated With Outcome After Cord Blood Transplantation in Children With Acute Leukemia

  2016cites this paper
• Haploidentical Hematopoietic Stem Cell Transplantation: Expanding the Horizon for Hematologic Disorders

  2016cites this paper
• Various Regimens of Total Body Irradiation for Hematopoietic Stem Cell Transplant.

  2016cites this paper
• A History of Allogeneic and Autologous Hematopoietic Cell Transplantation

  2016cites this paper
• Hematopoietic Stem Cell Transplantation for Chronic Myeloid Leukemia

  2016cites this paper
• Reduced-Intensity Transplantation for Lymphomas Using Haploidentical Related Donors Versus HLA-Matched Sibling Donors: A Center for International Blood and Marrow Transplant Research Analysis.

  2016cites this paper
• CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Peripheral Blood Stem Cell Transplantation From Unrelated Donors: A Comparison With Marrow Transplantation

  2016cites this paper
• Unrelated alternative donor transplantation for severe acquired aplastic anemia: a study from the French Society of Bone Marrow Transplantation and Cell Therapies and the EBMT Severe Aplastic Anemia Working Party

  2016cites this paper
• CD123 redirected multiple virus-specific T cells for acute myeloid leukemia.

  2016cites this paper
• Effect of HLA mismatching at HLA-A, -B, and -DRB1 for umbilical-cord blood transplantation in Taiwan.

  2016cites this paper
• Clofarabine and Busulfan Conditioning Facilitates Engraftment and Provides Significant Anti-Tumor Activity in Non-Remission Hematologic Malignancies Running Title: CloBu4 conditioning for HSCT

  2016cites this paper
• [Vaccination of adult patients receiving hematopoietic stem cell transplantation: Perspective of Costa Rica].

  2016cites this paper
• Biological significance of HLA locus matching in unrelated donor bone marrow transplantation.

  2015cites this paper
• High pre-transplant TREC levels indicate good prognosis after hematopoietic stem cell transplantation

  2015cites this paper
• Optimisation of a quantitative polymerase chain reaction-based strategy for the detection and quantification of human herpesvirus 6 DNA in patients undergoing allogeneic haematopoietic stem cell transplantation

  2015cites this paper
• Antimicrobial Prophylaxis in Hematology

  2015cites this paper
• Tissue typing and its role in transplantation

  2015cites this paper
• Comparable outcome after single-antigen-mismatched versus matched unrelated donor haematopoietic cell transplantation

  2015cites this paper
• Sca1(+) mesenchymal stromal cells inhibit graft-versus-host disease in mice after bone marrow transplantation.

  2015cites this paper
• History, Current Results, and Research in Marrow Transplantation

  2015cites this paper
• Genome-wide surveillance of mismatched alleles for graft-versus-host disease in stem cell transplantation.

  2015cites this paper
• Safe Marriage for Prevention of Thalassaemia: Sri Lankan Experience, Appraisal of the Concepts and Challenges of Implementation

  2015cites this paper
• The 100 most cited publications in transplantation.

  2014cites this paper
• Mycophenolate mofetil use after unrelated hematopoietic stem cell transplantation for prophylaxis and treatment of graft‐vs.‐host disease in adult patients in Japan

  2014cites this paper
• Blocking activator protein 1 activity in donor cells reduces severity of acute graft-versus-host disease through reciprocal regulation of IL-17-producing T cells/regulatory T cells.

  2014cites this paper
• Medullary allotransplant in acute myeloblastic leukemia in a child

  2014cites this paper
• Graft Versus Host Disease: From Basics to the Clinic

  2014cites this paper
• Molekulargenetische Analyse der minor Histokompatibilitäts-Antigene (mHag) und deren Relevanz für die allogene Blutstammzell-Transplantation

  2014cites this paper
• Methods of freezing cord blood hematopoietic stem cells

  2014cites this paper
• Omacetaxine for treatment-resistant or treatment-intolerant adult chronic myeloid leukemia.

  2014cites this paper
• Expansion of donor-reactive host T cells in primary graft failure after allogeneic hematopoietic SCT following reduced-intensity conditioning

  2014cites this paper
• Umbilical Cord Blood Banking

  2014cites this paper
• HLA Typing in Support of Hematopoietic Cell Transplantation from Unrelated Donors

  2013cites this paper
• mechanism acute graft-versus-host disease and implication for its molecular High-risk HLA allele mismatch combinations responsible for severe

  2013cites this paper
• hematologic malignancies transplantation and cord blood transplantation for adult patients with Single-institute comparative analysis of unrelated bone marrow

  2013cites this paper
• Chapter 40 – Transplantation Genetics

  2013cites this paper
• UNIVERSITÀ DEGLI STUDI DI MILANO

  2013cites this paper
• donors in pediatric leukemia Transplantation of highly purified CD34+ progenitor cells from unrelated

  2013cites this paper
• Peripheral-blood versus bone marrow stem cells.

  2013cites this paper
• non-permissive mismatches for hematological stem cell transplantation A T cell epitope encoded by a subset of HLA-DPB1 alleles determines

  2013cites this paper
• The recipient CXCL10 + 1642C>G variation predicts survival outcomes after HLA fully matched unrelated bone marrow transplantation.

  2013influential citation
• Comparação entre os biomarcadores inflamatórios procalcitonina (PCT), interleucina-6 (IL-6) e proteína-C reativa (PCR) para diagnóstico infeccioso e evolução de febre em pacientes neutropênicos submetidos a transplante de células tronco hematopoiéticas (TCTH)

  2013cites this paper
• donors allogeneic peripheral blood stem cell transplantation using unrelated Increased risk of extensive chronic graft-versus-host disease after

  2013cites this paper
• and costs transplantation for hematologic diseases: clinical outcome, quality of life, Comparison of T-cell depleted and non-T-cell depleted unrelated donor

  2013cites this paper
• Treatment of graft failure after allogeneic hematopoietic stem cell transplantation: current status

  2013cites this paper
• malignancy infusion may induce remission in patients with refractory hematologic Low-dose total body irradiation followed by allogeneic lymphocyte

  2013cites this paper
• Peripheral-blood versus bone marrow stem cells.

  2013cites this paper
• Clinical outcomes of allogeneic stem cell transplantation for relapsed or refractory follicular lymphoma: a retrospective analysis by the Fukuoka Blood and Marrow Transplantation Group

  2013cites this paper
• Evaluation of Maximal Sterile Barrier Precautions for Prevention of Infection at a Central Venous Catheter Site

  2013cites this paper
• colony-stimulating factor in children with acquired aplastic anemia cyclosporine, and danazol with or without human granulocyte Immunosuppressive therapy using antithymocyte globulin,

  2013cites this paper
• patients with first chronic phase chronic myeloid leukemia cells as compared with bone marrow from HLA-identical unrelated donors in survival after transplantation of peripheral blood stem - Improved disease-free

  2013cites this paper
• marrow from unrelated donors: the effect of donor age Donor characteristics as risk factors in recipients after transplantation of bone

  2013cites this paper
• Microsatellite scanning of the immunogenome for associations with graft-versus-host disease following haematopoietic stem cell transplantation

  2012cites this paper
• Ex vivo fucosylation improves human cord blood engraftment in NOD-SCID IL-2R γ null (NSG) mice

  2012cites this paper
• addback from unrelated adult donors in paediatric allogeneic stem cell transplantation recipients

  2012cites this paper
• T cell depletion utilizing CD34+ stem cell selection and CD3+ addback from unrelated adult donors in paediatric allogeneic stem cell transplantation recipients

  2012cites this paper
• Ex vivo fucosylation improves human cord blood engraftment in NOD-SCID IL-2Rγ(null) mice.

  2012cites this paper
• Transplantation in the onco-hematology field: focus on the manipulation of αβ and γδ T cells.

  2012cites this paper
• The role of the extracorporeal photopheresis in the management of the graft-versus-host disease.

  2012cites this paper
• Concise Review: Mesenchymal Stem Cells and Translational Medicine: Emerging Issues

  2012cites this paper
• STAT3 transcription factor promotes instability of nTreg cells and limits generation of iTreg cells during acute murine graft-versus-host disease.

  2012cites this paper
• Effects of conditioning regimens and T cell depletion in hematopoietic cell transplantation for primary immune deficiency.

  2012cites this paper
• Eltrombopag, a thrombopoietin receptor agonist, enhances human umbilical cord blood hematopoietic stem/primitive progenitor cell expansion and promotes multi-lineage hematopoiesis.

  2012cites this paper
• Apoptotic cells in allogeneic hematopoietic stem cell transplantations: “turning trash into gold”

  2012cites this paper